US Edition
News from The Caswell Messenger
Top The Caswell Messenger News
Cancer · United StatesIncludes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPDAdditional 11 programmes to be developed by Hengrui Pharma and optioned by GSK following phase I completionSee the Story
Hengrui Pharma and GSK Enter Agreements to Develop up to 12 Innovative Medicines Across Respiratory, Immunology & Inflammation and Oncology
58% Center coverage: 44 sources
Guangzhou · GuangzhouGUANGZHOU, China, July 27, 2025 /PRNewswire/ -- The 27th China (Guangzhou) International Building Decoration Fair (CBD Fair Guangzhou), held in tandem with the Guangzhou International Bath & Sanitary Ware Fair (CBS Fair), concluded on July 11. Spanning 300,000 square meters,…See the Story
CBD Guangzhou 2025 Wraps Up with International Attendance Rising by 47.22%
55% Center coverage: 38 sources
Taipei · TaipeiTAIPEI, July 23, 2025 /PRNewswire/ -- Nvidia is preparing to enter a new phase in the memory market by planning to deploy between 600,000 and 800,000 SOCAMM modules in 2025. This initiative positions SOCAMM as a potential successor to high-bandwidth…See the Story
DIGITIMES ASIA: Nvidia explores SOCAMM deployment for next-gen AI systems
Coverage: 18 sources
